Related Experiment Video
Updated: Feb 5, 2026

A Modified Method for Heterotopic Mouse Heart Transplantion
Published on: June 23, 2014
Interaction of Donor and Recipient Age: Do Older Heart Transplant Recipients Require Younger Hearts?
Malini Daniel1, Carol Chen1, Jennifer Chung1
1Division of Cardiovascular Surgery, Department of General Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.
Insights
Older heart transplant recipients (60+) face higher mortality risk with older donor hearts (50+). Careful selection allows using donor hearts up to age 50 without compromising survival outcomes.
Area of Science:
- Cardiology
- Transplantation Medicine
- Geriatric Medicine
Background:
- Older heart transplant candidates (60+ years) often have comorbidities impacting survival.
- The influence of donor heart age on outcomes in this population is critical.
- Hypothesis: Comorbidities and donor heart age significantly affect survival in older heart transplant recipients.
Purpose of the Study:
- To evaluate the impact of donor heart age on survival in patients aged 60 years or older undergoing heart transplantation.
- To determine if older donor hearts (allografts) can be safely used in older recipients.
Main Methods:
- Analysis of United Network for Organ Sharing database for heart transplant recipients aged 60+.
- Local regression to identify donor age inflection point for mortality risk.
- Kaplan-Meier and Cox proportional hazard modeling to compare survival between younger and older donor heart groups.
Main Results:
- An inflection point for increased mortality risk was observed around 50 years of donor age.
- Five-year survival was lower in recipients of older donor hearts (67%) compared to younger donor hearts (73%).
- Patients receiving older donor hearts (50+) had a 30% increased risk of mortality by 5 years.
Conclusions:
- Older heart transplant recipients receiving older donor hearts (50+) face significantly increased mortality risk.
- Careful donor allograft selection is essential.
- Utilizing donor hearts up to 50 years of age may be acceptable for older recipients.
Background:
Older patients (aged 60 years or more) awaiting heart transplant often have comorbidities that may limit overall survival independent of cardiac status. We hypothesized that these comorbidities have a more-limiting impact on survival than age of donor heart and that older allografts might be utilized in these patients without compromising outcomes.
Methods:
We identified all transplant recipients aged more than 60 years in the United Network for Organ Sharing database. Local regression analysis detected the point above which increasing donor age incurred increasing risk of mortality, above and below which two cohorts were defined. Kaplan-Meier analysis compared cumulative 5-year survival between groups. Cox proportional hazard modeling was then used to determine the hazards of death in the two groups.
Results:
An inflection point in posttransplant survival was detected near donor age 50 years. Of 14,113 older recipients studied, 86% received younger donor hearts (less than 50 years of age), and 14% received advanced age allografts (50 years of age or more). Baseline characteristics were comparable between groups except more recipients had left ventricular assist devices at time of transplant in the younger donor group (15% versus 9%, p < 0.001). Five-year survival was significantly lower among recipients receiving advanced age hearts compared with those receiving younger hearts (67% versus 73%, log rank p < 0.001). Adjusting for relevant recipient baseline characteristics, patients receiving advanced age hearts were 30% more likely to die by 5 years compared with patients receiving younger hearts.
Conclusions:
Transplant recipients aged 60 years and more who receive advanced age donor hearts (50 years or more) have a significantly increased risk of mortality. With careful allograft selection, use of donor hearts to age 50 may be acceptable among older transplant recipients.
Related Concept Videos
Anatomy of the Heart
Anatomy of the Heart
The heart has three layers: the innermost endocardium, the muscular myocardium, and the outer epicardium, all working together for optimal cardiac function.
Chambers of the Heart
The heart is made up of four...
Overview of the Heart
The heart's structure...
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Conduction System of the Heart
This system relies on the unique properties of nodal and Purkinje cells:...
Chambers of the Heart
Deoxygenated blood from the body is received in the right...

